The company's clinic offers protocol-certified practitioners who deliver therapeutic processes and post-integration analysis, aiming to enhance therapy for clinicians. In addition, MindSetting conducts research on the efficacy of psychedelic treatments and develops treatment protocols. The company was acquired by Optimind Pharma in September 2022, although the terms of the transaction were not disclosed. MindSetting's mission is to increase access to quality psychedelic therapy through patient care and practitioner training, utilizing the science of psychology and the power of psychedelic medicine to help people transform their lives.